Acadia Pharmaceuticals Inc. (ACAD)
BMV
453.75
0.00 (0.00%)
Closed
Aug 21, 2026
Day's Range
453.75453.75
52 wk Range
362.00509.00
Financial Statements - ACAD - Acadia Pharmaceuticals Inc.
Revenue
1.07B▲ 11.9%
Net Income
391.00M▲ 72.7%Net Margin 36.5%
EBITDA
116.57M▲ 351.5%
Free Cash Flow
105.14M▼ 33.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 1.07B | 957.79M |
| Cost of Goods | 88.99M | 81.84M |
| Gross Profit | 982.50M | 875.95M |
 Operating Expense | - | - |
| Operating Income | 104.81M | 84.27M |
| Non-Operating Interest | - | - |
| Other Income Expense | 2.37M | 148.33M |
| Pre Tax Income | 138.90M | 258.07M |
| Income Tax | -252.09M | 31.62M |
| Net Income | 391M | 226.45M |
| EPS Basic | 2.32 | 1.37 |
| EPS Diluted | 2.3 | 1.36 |
| Basic Shares Outstanding | 168.35M | 165.71M |
| Diluted Shares Outstanding | 168.35M | 165.71M |
| Ebit | 104.81M | 84.27M |
| Ebitda | 116.57M | -46.35M |
| Net Income Continuous Operations | 391M | 226.45M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
